Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014
- PMID: 29678312
- PMCID: PMC6080305
- DOI: 10.1016/j.annepidem.2018.03.001
Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014
Abstract
Purpose: Current literature shows different findings on the contemporary trends of distant-stage prostate cancer incidence, in part, due to low study population coverage and wide age groupings. This study aimed to examine the stage-specific incidence rates and trends of prostate cancer by age (5-year grouping), race, and ethnicity using nationwide cancer registry data.
Methods: Data on prostate cancer cases came from the 2004-2014 United States Cancer Statistics data set. We calculated stage-specific incidence and 95% confidence intervals by age (5-year age grouping), race, and ethnicity. To measure the changes in rates over time, we calculated annual percentage change (APC).
Results: We identified 2,137,054 incident prostate cancers diagnosed during 2004-2014, with an age-adjusted incidence rate of 453.8 per 100,000. Distant-stage prostate cancer incidence significantly decreased during 2004-2010 (APC = -1.2) and increased during 2010-2014 (APC = 3.3). Significant increases in distant prostate cancer incidence also occurred in men aged older than or equal to 50 years except men aged 65-74 and older than or equal to 85 years, in men with white race (APC = 3.9), and non-Hispanic ethnicity (APC = 3.5).
Conclusions: Using data representing over 99% of U.S. population, we found that incidence rates of distant-stage prostate cancer significantly increased during 2010-2014 among men in certain ages, in white, and with non-Hispanic ethnicity.
Keywords: Cancer incidence; Cancer stage; Prostate cancer.
Published by Elsevier Inc.
Conflict of interest statement
No financial conflict of interest for all authors and no funding sources claimed.
References
-
- Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. SEER cancer statistics review, 1975—2014. Bethesda, MD: National Cancer Institute; 2017. https://seer.cancer.gov/csr/1975_2014. [Accessed 10 September 2017].
-
- Moyer VA, U.S. Preventive Service Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012;157(2):120–34. - PubMed
-
- Jemal A, Ma J, Siegel R, Fedewa S, Brawley O, Ward EM. Prostate cancer incidence rates 2 years after the US Preventive Services Task Force Recommendations Against Screening.JAMA Oncol 2016;2(12):1657–60. - PubMed
-
- Jemal A, Fedewa SA, Ma J, Siegel R, Lin CC, Brawley O, et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA 2015;314(19):2054–61. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
